Paper20163522
TRPM3 is expressed in sphingosine-responsive myelinating oligodendrocytes.
Hoffmann A and 10 others. J Neurochem, 2010. Cited by 66 papers, by iCite.
Cite this record
ConductScience Library. TRPM3 is expressed in sphingosine-responsive myelinating oligodendrocytes. Papers, record 20163522. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20163522
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain | Major topic |
| Myelin Sheath | Major topic |
| Oligodendroglia | Major topic |
| Sphingosine | Major topic |
| TRPM Cation Channels | Major topic |
| Alternative Splicing | |
| Animals | |
| Animals, Newborn | |
| Calcium Signaling | |
| Cell Membrane Permeability | |
| Homeostasis | |
| Neuroglia | |
| Organ Culture Techniques | |
| Rats | |
| Rats, Wistar |
Source PubMed
Cited by44
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42470577 | Intranasal 6-OHDA Induces TRPM3-mediated Neuroinflammation in the pVTA: A Preclinical Early-stage Parkinson's Disease Model. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42470577 | PubMed |
| 41958982 | Disease-associated microRNA, miR-9-2, regulates timing of retinal progenitor cell competence and maintenance of Müller glial identity. | bioRxiv | 2026 | https://conductscience.org/library/papers/41958982 | PubMed |
| 41760388 | Nanoparticles-Mediated Modulation of TRP Channels: Advances and Therapeutic Potential. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2026 | https://conductscience.org/library/papers/41760388 | PubMed |
| 41399206 | Transient Receptor Potential Channels as Key Regulators of Neuroinflammation in Neurological Disorders: Mechanistic Insights, Therapeutic Potentials, and Future Directions. | CNS Neurosci Ther | 2025 | https://conductscience.org/library/papers/41399206 | PubMed |
| 40500497 | Physiology of Oligodendroglia. | Adv Neurobiol | 2025 | https://conductscience.org/library/papers/40500497 | PubMed |
| 39749750 | Phenotype Spectrum of TRPM3-Associated Disorders. | Ann Neurol | 2025 | https://conductscience.org/library/papers/39749750 | PubMed |
| 39294615 | TRPM3, TRPM4, and TRPM5 as thermo-sensitive channels. | J Physiol Sci | 2024 | https://conductscience.org/library/papers/39294615 | PubMed |
| 39007920 | Therapeutic potential of transient receptor potential (TRP) channels in psychiatric disorders. | J Neural Transm (Vienna) | 2024 | https://conductscience.org/library/papers/39007920 | PubMed |
| 36844925 | On the modulation of TRPM channels: Current perspectives and anticancer therapeutic implications. | Front Oncol | 2022 | https://conductscience.org/library/papers/36844925 | PubMed |
| 36648066 | Gain-of-function variants in the ion channel gene TRPM3 underlie a spectrum of neurodevelopmental disorders. | Elife | 2023 | https://conductscience.org/library/papers/36648066 | PubMed |
| 35886939 | Sphingolipid Catabolism and Glycerophospholipid Levels Are Altered in Erythrocytes and Plasma from Multiple Sclerosis Patients. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35886939 | PubMed |
| 33853504 | The newest TRP channelopathy: Gain of function TRPM3 mutations cause epilepsy and intellectual disability. | Channels (Austin) | 2021 | https://conductscience.org/library/papers/33853504 | PubMed |
| 33732703 | TRPM3 in Brain (Patho)Physiology. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/33732703 | PubMed |
| 33291725 | TRPM Channels in Human Diseases. | Cells | 2020 | https://conductscience.org/library/papers/33291725 | PubMed |
| 32409508 | Spontaneous Local Calcium Transients Regulate Oligodendrocyte Development in Culture through Store-Operated Ca2+ Entry and Release. | eNeuro | 2020 | https://conductscience.org/library/papers/32409508 | PubMed |
| 32121306 | Strategies for Neuroprotection in Multiple Sclerosis and the Role of Calcium. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32121306 | PubMed |
| 32070426 | TRPM3_miR-204: a complex locus for eye development and disease. | Hum Genomics | 2020 | https://conductscience.org/library/papers/32070426 | PubMed |
| 31614447 | Ceramide and Sphingosine Regulation of Myelinogenesis: Targeting Serine Palmitoyltransferase Using microRNA in Multiple Sclerosis. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31614447 | PubMed |
| 31547139 | Regulation of Membrane Calcium Transport Proteins by the Surrounding Lipid Environment. | Biomolecules | 2019 | https://conductscience.org/library/papers/31547139 | PubMed |
| 31014226 | Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients. | Mol Med | 2019 | https://conductscience.org/library/papers/31014226 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20163522
GET https://conductscience.org/api/papers/v1/20163522/cited_by?page=2